Edition:
United Kingdom

Bioblast Pharma Ltd (ORPN.OQ)

ORPN.OQ on NASDAQ Stock Exchange Capital Market

2.21USD
8:59pm GMT
Change (% chg)

$-0.01 (-0.45%)
Prev Close
$2.22
Open
$2.21
Day's High
$2.28
Day's Low
$2.06
Volume
11,112
Avg. Vol
9,417
52-wk High
$8.55
52-wk Low
$1.64

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Jun '17 0.00 -0.496
Mar '17 0.00 -0.815
FY 2016 Dec '16 0.00 -0.939
Sep '16 0.00 -1.424
Jun '16 0.00 -1.124
Mar '16 0.00 -1.588
FY 2015 Dec '15 0.00 -1.697
Sep '15 0.00 -1.248
Jun '15 0.00 -1.295
Mar '15 0.00 -1.159
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 90.05 33.00
P/E High - Last 5 Yrs. -- 297.92 45.54
P/E Low - Last 5 Yrs. -- 95.76 24.39
Beta -- 0.84 0.88
Price to Sales (TTM) -- 84.40 5.19
Price to Book (MRQ) 1.56 13.58 5.37
Price to Tangible Book (MRQ) 1.56 13.43 6.70
Price to Cash Flow (TTM) -- 78.72 23.64
% Owned Institutions 17.02 6.35 1.30

Dividends

  Company industry sector
Dividend Yield -- 0.29 1.48
Dividend Yield - 5 Year Avg -- 0.27 1.49
Dividend 5 Year Growth Rate -- 1.92 5.19
Payout Ratio(TTM) -- 17.65 43.23

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 446.02 8.79
Sales (TTM) vs TTM 1 Yr. Ago -- 70.22 5.34
Sales - 5 Yr. Growth Rate -- 33.91 10.47
EPS (MRQ) vs Qtr. 1 Yr. Ago 55.85 30.06 17.28
EPS (TTM) vs TTM 1 Yr. Ago 35.03 -- --
EPS - 5 Yr. Growth Rate -- 44.66 10.98
Capital Spending - 5 Yr. Growth Rate -- 41.51 15.36

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.71 2.20
Current Ratio (MRQ) 6.96 5.13 3.00
LT Debt to Equity (MRQ) 0.00 19.14 10.52
Total Debt to Equity (MRQ) 0.00 20.75 14.50
Interest Coverage (TTM) -- -112.86 34.12

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 44.40 54.63
Gross Margin - 5 Yr. Avg. -- 52.79 52.08
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- -228.86 15.56
Operating Margin (TTM) -- -436.91 9.35
Operating Margin - 5 Yr. Avg. -- -244.73 11.26
Pre-Tax Margin (TTM) -- -412.15 10.17
Pre-Tax Margin - 5 Yr. Avg. -- -243.72 11.70
Net Profit Margin (TTM) -- -413.82 6.45
Net Profit Margin - 5 Yr. Avg. -- -247.81 7.96
Effective Tax Rate (TTM) -- 24.55 23.28
Effective Tax Rate - 5 Yr. Avg. -- 19.80 24.10

Efficiency

  Company industry sector
Revenue/Employee (TTM) -- 26,027,394 882,639,287
Net Income/Employee (TTM) -- 3,373,680 103,842,182
Receivable Turnover (TTM) -- 17.75 5.74
Inventory Turnover (TTM) -- 2.03 3.36
Asset Turnover (TTM) 0.00 0.37 0.94

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -107.24 -0.60 11.07
Return on Assets - 5 Yr. Avg. -- -0.17 12.57
Return on Investment (TTM) -119.23 2.31 14.52
Return on Investment - 5 Yr. Avg. -- 3.33 16.44
Return on Equity (TTM) -119.23 2.98 15.97
Return on Equity - 5 Yr. Avg. -- 6.46 17.58
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % 6.71 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Bioblast Pharma Ltd

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 16.68%
# of Holders: 4
Total Shares Held: 557,456
3 Mo. Net Change: -11,233
# New Positions: 0
# Closed Positions: 6
# Increased Positions: 1
# Reduced Positions: 6
# Net Buyers: -5
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.